Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gut microbiota ecological niches refer to the specialized spatial, temporal, and nutritional environments within the gastrointestinal tract that support the colonization and function of diverse microbial communities (NIH, 2024; MDPI, 2024). These niches are shaped by host factors such as pH, oxygen gradients, bile salts, and immune effectors, as well as by the availability of dietary and host-derived nutrients (NIH, 2024; ResearchGate, 2023). The maintenance of these niches is critical for colonization resistance, where resident microbes prevent the establishment of pathogens through competitive exclusion and metabolic cross-feeding (NIH, 2024). Dysbiosis, or the disruption of these ecological niches, is linked to numerous conditions, including inflammatory bowel disease (IBD), metabolic disorders like obesity and type 2 diabetes, and susceptibility to infections such as Clostridium difficile (Houston Methodist, 2024; NIH, 2011). Therapeutic strategies targeting these niches include the use of probiotics, prebiotics, and fecal microbiota transplants (FMT) to restore microbial balance and functional homeostasis (NIH, 2020; Pharmaceutical Journal, 2022). Emerging research also highlights the role of these niches in modulating the efficacy of systemic drugs, such as metformin and immune checkpoint inhibitors, through microbial metabolism (NIH, 2020; ResearchGate, 2025).
Competitive exclusion of pathogens, metabolic cross-feeding, niche saturation, production of antimicrobial peptides, and modulation of host immune receptors through microbial metabolites.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gut microbiota ecological niches.